• Indian Stocks Swing Between Gains, Losses Before Inflation Data
  • Level Global Co-Founder Gets 6 1/2-Year Prison Sentence
  • Vivus Adds Two New Directors to Board Amid Pressure
  • Elan to Pay $1 Billion for Stake in Theravance Royalties
  • AstraZeneca, Cubist, Astellas Said to Make Bids for Optimer
  • Ranbaxy to Pay $500 Million to End Criminal, Civil Cases
  • Lazard Capital Markets Weighs Sale Among Strategic Options
  • Ranbaxy Agrees to Pay at Least $350 Million to Settle U.S. Suit
  • The Top Ten Stocks for Monday, May 13
  • Europe Eases Corporate Tax Dodge as Worker Burdens Rise
  • Human Immune-Boosting Cancer Drugs Seen Extending Lives
« Previous 1 2 3 4 5 Next »